Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xintela AB | 255,000 | net | 12 Jul 2022 | tx 3+255,000 |
| Xbrane Biopharma AB (publ) | 152,060 | net | 13 Mar 2024 | tx 8+152,060 |
| Integrum AB | 98,518 | net | 11 Jan 2023 | tx 5+98,518 |
| Xintela | 20,000 | net | 10 Feb 2017 | tx 1+20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 25,480 | 11.50 SEK | |
| 19 Sept 2023 | PURCHASE | Xbrane Biopharma AB (publ) | 5,000 | 29.90 SEK | |
| 11 Jan 2023 | PURCHASE | Integrum AB | 20,000 | 15.55 SEK | |
| 12 Jul 2022 | PURCHASE | Xintela AB | 210,000 | 0.25 SEK | |
| 27 Jan 2022 | PURCHASE | Integrum AB | 20,000 | 8.88 SEK | derivfirst after silence |
| 09 Nov 2020 | OTHER | Xintela AB | 22,500 | 2.28 SEK | |
| 09 Nov 2020 | OTHER | Xintela AB | 22,500 | 0.00 SEK | deriv |
| 12 Oct 2020 | PURCHASE | Integrum AB | 20,000 | 2.08 SEK | deriv |
| 09 Jun 2020 | PURCHASE | Integrum AB | 18,518 | 5.40 SEK | |
| 30 Oct 2019 | PURCHASE | Integrum AB | 20,000 | 0.80 SEK | deriv |
| 12 Jul 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 3,612 | 33.50 SEK | |
| 25 Mar 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 2,468 | 30.00 SEK | |
| 02 Apr 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 6,500 | 30.00 SEK | |
| 20 Mar 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 104,000 | 0.24 SEK | deriv |
| 06 Apr 2018 | PURCHASE | Xbrane Biopharma AB (publ) | 3,000 | 5.88 SEK | |
| 06 Apr 2018 | PURCHASE | Xbrane Biopharma AB (publ) | 2,000 | 61.04 SEK | |
| 10 Feb 2017 | OTHER | Xintela | 20,000 | 5.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 27 Jan 2022.